| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Toxicology | 43 / 131 | 67th | Q2 |
| Biomedical Engineering | 123 / 342 | 64th | Q2 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Nanotoxicology
Nanotoxicology is Scopus-indexed (Q2, CiteScore 6.1), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 1743-5390Verify ISSN ↗1743-5404Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Quick answers
Is Nanotoxicology indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2007–present, best quartile Q2, CiteScore 6.1.
What quartile is Nanotoxicology in Scopus?
Nanotoxicology is Q2 in Toxicology (rank 43 of 131) and Q2 in Biomedical Engineering (rank 123 of 342), by CiteScore 2025.
What is the impact factor of Nanotoxicology?
Nanotoxicology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.1, which places it in quartile Q2 at the 67th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.693, quartile Q2, with an H-index of 116.
Who publishes Nanotoxicology and what is its ISSN?
Nanotoxicology is published by Taylor and Francis Ltd. Its print ISSN is 1743-5390 and its online ISSN is 1743-5404.
Is Nanotoxicology covered under ONOS in India?
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Is Nanotoxicology in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is Nanotoxicology open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Nanotoxicology? — open metrics via OpenAlex
Nanotoxicology has an h-index of 129 and a 2-year mean of 5.43 citations per paper (OpenAlex). Its Scopus CiteScore is 6.1, quartile Q2. On 2-year citations it ranks #20 of 128 Scopus journals in Toxicology.
Nanotoxicology published 34 papers in 2025; its busiest recent year was 2018 with 107. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Nanotoxicology? — latest 98 articles, 2023–2026
In its latest 98 research articles (2023–2026), authors are most often from India (16%), United States (12.6%) and Iran (8.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Nanotoxicology? — indicators, not proof of misconduct
Scopus status: Active. 2 retracted papers are recorded (1.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 2 · 1.4 per 1,000 papers
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.